PURE BIOSCIENCE, INC. Quarterly Debt-to-equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Pure Bioscience, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q2 2024.
  • Pure Bioscience, Inc. Debt-to-equity for the quarter ending July 31, 2024 was -176 %.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 -176 Jul 31, 2024
Q1 2024 -270 Apr 30, 2024
Q2 2020 44.7 -1.55 -3.35% Jul 31, 2020
Q1 2020 57.5 +2.05 +3.7% Apr 30, 2020
Q4 2019 63.2 +14.4 +29.6% Jan 31, 2020
Q3 2019 58 +21 +56.6% Oct 31, 2019
Q2 2019 46.2 +17.2 +59% Jul 31, 2019
Q1 2019 55.4 +15.4 +38.3% Apr 30, 2019
Q4 2018 48.7 -5.89 -10.8% Jan 31, 2019
Q3 2018 37.1 -27.1 -42.2% Oct 31, 2018
Q2 2018 29.1 -60.4 -67.5% Jul 31, 2018
Q1 2018 40.1 -27.1 -40.3% Apr 30, 2018
Q4 2017 54.6 -135 -71.2% Jan 31, 2018
Q3 2017 64.2 +871 Oct 31, 2017
Q2 2017 89.5 +605 Jul 31, 2017
Q1 2017 67.1 +434 Apr 30, 2017
Q4 2016 190 +904 Jan 31, 2017
Q3 2016 -807 -900 -962% Oct 31, 2016
Q2 2016 -516 -536 -2665% Jul 31, 2016
Q1 2016 -366 -397 -1316% Apr 30, 2016
Q4 2015 -714 -753 -1957% Jan 31, 2016
Q3 2015 93.6 +29.3 +45.6% Oct 31, 2015
Q2 2015 20.1 -295 -93.6% Jul 31, 2015
Q1 2015 30.1 -597 -95.2% Apr 30, 2015
Q4 2014 38.5 -970 -96.2% Jan 31, 2015
Q3 2014 64.3 -531 -89.2% Oct 31, 2014
Q2 2014 315 +90.3 +40.2% Jul 31, 2014
Q1 2014 627 +455 +266% Apr 30, 2014
Q4 2013 1.01K +862 +585% Jan 31, 2014
Q3 2013 595 +465 +358% Oct 31, 2013
Q2 2013 224 +109 +94.9% Jul 31, 2013
Q1 2013 171 +114 +200% Apr 30, 2013
Q4 2012 147 Jan 31, 2013
Q3 2012 130 Oct 31, 2012
Q2 2012 115 Jul 31, 2012
Q1 2012 57.1 Apr 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.